4.6 Article

18F-GP1 Positron Emission Tomography and Bioprosthetic Aortic Valve Thrombus

Journal

JACC-CARDIOVASCULAR IMAGING
Volume 15, Issue 6, Pages 1107-1120

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2021.11.015

Keywords

18F-GP1; bioprosthetic aortic valve replacement; positron emission tomography; computed tomography; thrombus

Funding

  1. British Heart Foundation, London, United Kingdom [RG/16/10/32375, PG/19/40/34422]
  2. National Health Service Research Scotland (NRS) through National Health Service Lothian Health Board
  3. British Heart Foundation [RG/16/10/32375, PG/19/40/34422, FS/ICRF/20/26002, FS/CRTF/20/24086, FS/14/78/31020, CH/09/002, RE/18/5/34216, FS/SCRF/21/32010]
  4. Scottish Imaging Network
  5. Michael Smith Foundation for Health Research
  6. Canadian Institutes of Health Research
  7. Canadian Research Chair in Advanced CardioPulmonary Imaging
  8. Jon DeHaan Award for Innovation in Cardiology
  9. Chief Scientist Office of the Scottish Government Health and Social Care Directorates [PCL/17/04]
  10. Wellcome Trust [WT103782AIA]

Ask authors/readers for more resources

This study utilized 18F-GP1 radiotracer to detect thrombus formation on bioprosthetic valves, and found that adherence of activated platelets is a common finding on these valves. The study also revealed that the uptake of 18F-GP1 is associated with the extent of thrombus formation and regresses with treatment.
BACKGROUND: Bioprosthetic valve thrombosis may have implications for valve function and durability. OBJECTIVES: Using a novel glycoprotein IIb/IIIa receptor radiotracer 18F-GP1, we investigated whether positron emission tomography (PET)-computed tomography (CT) could detect thrombus formation on bioprosthetic aortic valves. METHODS: Ex vivo experiments were performed on human platelets and explanted bioprosthetic aortic valves. In a prospective cross-sectional study, patients with either bioprosthetic or normal native aortic valves underwent echocardiography, CT angiography, and 18F-GP1 PET-CT. RESULTS: Flow cytometric analysis, histology, immunohistochemistry, and autoradiography demonstrated selective binding of 18F-GP1 to activated platelet glycoprotein IIb/IIIa receptors and thrombus adherent to prosthetic valves. In total, 75 participants were recruited: 53 with bioprosthetic valves (median time from implantation 37 months [IQR: 12-80 months]) and 22 with normal native aortic valves. Three participants had obstructive valve thrombosis, and a further 3 participants had asymptomatic hypoattenuated leaflet thickening on CT angiography. All bioprosthetic valves, but none of the native aortic valves, demonstrated focal 18F-GP1 uptake on the valve leaflets: median maximum target-to-background ratio 2.81 (IQR: 2.29-3.48) vs 1.43 (IQR: 1.28-1.53) (P < 0.001). Higher 18F-GP1 uptake was independently associated with duration of valve implantation and hypoattenuated leaflet thickening. All 3 participants with obstructive valve thrombosis were anticoagulated for 3 months, leading to resolution of their symptoms, improvement in mean valve gradients, and a reduction in 18F-GP1 uptake. CONCLUSIONS: Adherence of activated platelets is a common and sustained finding on bioprosthetic aortic valves. 18F-GP1 uptake is higher in the presence of thrombus, regresses with anticoagulation, and has potential use as an adjunctive clinical tool. (C) 2022 by the American College of Cardiology Foundation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available